Page 5 - ரௌபகஷ மூலதனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ரௌபகஷ மூலதனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ரௌபகஷ மூலதனம் Today - Breaking & Trending Today

Codexis (CDXS) is Roubaix Capital's Star Performer During the Q4 of 2020

Codexis (CDXS) is Roubaix Capital’s Star Performer During the Q4 of 2020
Roubaix Capital LLC, an investment management firm, published its ‘Roubaix Fund Composite’ fourth-quarter 2020 Investor Letter – a copy of which can be downloaded here. A net return of 26.63% was recorded by the fund for the Q4 of 2020, outperforming its HFRI Equity Hedge benchmark that delivered a 14.50% return but below its Russell 2000 index that had a 31.37% return. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Roubaix Capital, in their Q4 2020 Investor Letter, said that Codexis, Inc. (NASDAQ: CDXS) was the top contributor for their portfolio in the fourth quarter of 2020. Codexis, Inc. is a premier protein engineering company that currently has a $1.6 billion market cap. For the past 3 months, CDXS delivered a decent 68.44% return and settled at $26.31 per share at the closing of February 12th. ....

Marcin Balcerzak Shutterstock , Roubaix Capital , Roubaix Fund , Codexis Inc , Federal Reserve , Roubaix Fund Composite , Code Evolver , Among Hedge , Insider Monkey , Free Daily Newsletter , ரௌபகஷ மூலதனம் , ரௌபகஷ நிதி , கூட்டாட்சியின் இருப்பு , ரௌபகஷ நிதி கலப்பு , குறியீடு பரிணாமம் , மத்தியில் ஹெட்ஜ் , உள் குரங்கு , இலவசம் தினசரி செய்திமடல் ,

Repro Med (KRMD): Top Detractor for Roubaix Capital in Q4'20

Repro Med (KRMD): Top Detractor for Roubaix Capital in Q4’20
Roubaix Capital LLC, an investment management firm, published its ‘Roubaix Fund Composite’ fourth-quarter 2020 Investor Letter – a copy of which can be downloaded here. A net return of 26.63% was recorded by the fund for the Q4 of 2020, outperforming its HFRI Equity Hedge benchmark that delivered a 14.50% return but below its Russell 2000 index that had a 31.37% return. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Roubaix Capital, in their Q4 2020 Investor Letter, said that Repro Med Systems, Inc. (NASDAQ: KRMD) was the largest detractor for their portfolio in the fourth quarter of 2020. Repro Med Systems, Inc. is a medical device designer and manufacturing company that currently has a $192 million market cap. For the past 3 months, KRMD delivered a 9.25% return and settled at $4.37 per share at the closing of February 12th. ....

Chaikom Shutterstock , Roubaix Capital , Roubaix Fund , Repro Med Systems Inc , Federal Reserve , Roubaix Fund Composite , Repro Med Systems , Med Systems , Among Hedge , Insider Monkey , Free Daily Newsletter , ரௌபகஷ மூலதனம் , ரௌபகஷ நிதி , ரிப்ரோ மேட் அமைப்புகள் இன்க் , கூட்டாட்சியின் இருப்பு , ரௌபகஷ நிதி கலப்பு , ரிப்ரோ மேட் அமைப்புகள் , மேட் அமைப்புகள் , மத்தியில் ஹெட்ஜ் , உள் குரங்கு , இலவசம் தினசரி செய்திமடல் ,

Roubaix Capital's Q4 2020 Investor Letter

Denver, Colorado-based Roubaix Capital LLC, an investment management firm, published its Roubaix Fund Composite fourth-quarter 2020 Investor Letter –. ....

United States , Roubaix Capital , Roubaix Fund , Colorado Based Roubaix Capital , Roubaix Fund Composite , ஒன்றுபட்டது மாநிலங்களில் , ரௌபகஷ மூலதனம் , ரௌபகஷ நிதி , கொலராடோ அடிப்படையிலானது ரௌபகஷ மூலதனம் , ரௌபகஷ நிதி கலப்பு ,